We are live on ! Find out more
CFM

Catalyst Funds Management Portfolio holdings

AUM $591M
1-Year Est. Return 71.09%
This Fund
S&P 500
This Quarter Est. Return
+18.48%
1 Year Est. Return
+71.09%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$662M
AUM Growth
+$300M
Cap. Flow
+$240M
Cap. Flow %
36.28%
Top 10 Hldgs %
28.08%
Holding
690
New
261
Increased
108
Reduced
89
Closed
211

Sector Composition

Rank Sector Weight
1 Technology 28.1%
2 Communication Services 12.78%
3 Financials 12.71%
4 Industrials 10.24%
5 Healthcare 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVM
451
Silvercorp Metals
SVM
$2.13B
$128K 0.02%
+20,300
New +$99.4K
BGS icon
452
B&G Foods
BGS
$285M
$125K 0.02%
+28,200
New +$123K
NFBK
453
DELISTED
Northfield Bancorp
NFBK
$120K 0.02%
+10,200
New +$117K
GPMT
454
Granite Point Mortgage Trust
GPMT
$63.7M
$120K 0.02%
40,064
+16,964
+73% +$46.9K
UGP icon
455
Ultrapar
UGP
$6.87B
$114K 0.02%
+27,900
New +$94.9K
MRAM icon
456
Everspin Technologies
MRAM
$354M
$108K 0.02%
+11,570
New +$78.6K
HYLN icon
457
Hyliion Holdings
HYLN
$663M
$107K 0.02%
+54,200
New +$90.2K
LCTX icon
458
Lineage Cell Therapeutics
LCTX
$257M
$105K 0.02%
62,400
-20,700
-25% -$24.5K
BDTX icon
459
Black Diamond Therapeutics
BDTX
$101M
$105K 0.02%
27,800
+9,300
+50% +$27.2K
CCCC icon
460
C4 Therapeutics
CCCC
$376M
$94.3K 0.01%
42,500
+14,200
+50% +$34.1K
MGNX icon
461
MacroGenics
MGNX
$235M
$91.7K 0.01%
54,600
+26,100
+92% +$42.2K
PLRX icon
462
Pliant Therapeutics
PLRX
$67.5M
$88.1K 0.01%
59,539
+25,524
+75% +$38.9K
ONL
463
Orion Office REIT
ONL
$148M
$84K 0.01%
31,100
+8,610
+38% +$23K
QIPT
464
DELISTED
Quipt Home Medical
QIPT
$83.1K 0.01%
31,845
+14,345
+82% +$33.1K
REKR icon
465
Rekor Systems
REKR
$83.8M
$80.4K 0.01%
51,200
+17,100
+50% +$21.6K
SVC
466
Service Properties Trust
SVC
$1.1B
$80.2K 0.01%
5,922
+1,981
+50% +$26.8K
SES icon
467
SES AI
SES
$186M
$78.2K 0.01%
46,800
-15,500
-25% -$18.5K
ZNTL icon
468
Zentalis Pharmaceuticals
ZNTL
$308M
$77.6K 0.01%
51,400
+24,600
+92% +$36.9K
HFRO
469
Highland Opportunities and Income Fund
HFRO
$407M
$68.6K 0.01%
+10,800
New +$63.3K
MQ icon
470
Marqeta
MQ
$1.8B
$57K 0.01%
2,700
-900
-25% -$21.3K
SABR icon
471
Sabre
SABR
$656M
$56.5K 0.01%
+30,900
New +$72.9K
TCRX icon
472
TScan Therapeutics
TCRX
$51.9M
$56K 0.01%
30,763
+12,763
+71% +$22.6K
STRO icon
473
Sutro Biopharma
STRO
$379M
$55.4K 0.01%
6,378
+2,528
+66% +$21.5K
ORGO icon
474
Organogenesis Holdings
ORGO
$308M
$54.4K 0.01%
12,900
-4,300
-25% -$20K
LXRX icon
475
Lexicon Pharmaceuticals
LXRX
$1.02B
$54.4K 0.01%
40,300
-13,400
-25% -$15.2K

Similar funds

Catalyst Funds Management's Q3 2025 Portfolio in Review

As of Q3 2025, Catalyst Funds Management held 690 positions worth $662M, up 83% from $362M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Catalyst Funds Management deployed $240M of net new capital in Q3 2025, opening 261 new positions and adding to 108 existing holdings. Its largest new stake was Apple: 149,200 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 19% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Tencent Music, an estimated $3.58M trimmed.

  • Catalyst Funds Management's largest Q3 2025 buy was Apple: 149,200 shares worth $38M.
  • Catalyst Funds Management added most to NVIDIA in Q3 2025, an estimated $14.8M increase.
  • Catalyst Funds Management's biggest Q3 2025 reduction was Tencent Music, cutting an estimated $3.58M.
  • Catalyst Funds Management fully exited Applovin in Q3 2025, selling an estimated $11.2M.
  • Catalyst Funds Management's ten largest holdings make up 28% of its $662M portfolio in Q3 2025.
  • Catalyst Funds Management opened 261 new positions and closed 211 in Q3 2025.
  • Catalyst Funds Management's portfolio value rose 83% quarter-over-quarter to $662M.

Based on Catalyst Funds Management's 13F filing for Q3 2025, filed 12 Nov 2025.